NCT04185272Recruiting
Butyrophilins Role in Colon Cancer
Role of Butyrophilins in Colon Cancers Aggressiveness Evaluation
Source: ClinicalTrials.gov · Last updated 1 Oct 2026
Brief summary (registry, in English)
quantification of BTNL molecules in colon cancer in order to determinate if their could be used as a prognostic marquer
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 2 Dec 2019
- Start date
- 30 Jun 2020
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Institut Paoli-Calmettes
- Diseases
- Colorectal cancer
- NCT number
- NCT04185272
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 30 Jun 2020 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient who received neoadjuvant therapy other than chemotherapy
- Patient treated with immune-suppressors or long-course corticosteroids \<12 months
Other illness
- Rectal cancer, colon cancer recurrence
- Emergency of colon cancer Surgery
- History of inflammatory disease of the digestive tract (Crohn's disease or ulcerative colitis)
Other
- Pregnant women or likely to be pregnant (without effective contraception) or breastfeeding,
- Person in urgent situation, person under legal protection measure, or unable to express his / her consent,
- Impossibility of submitting to the medical examination of the test for geographical, social or psychological reasons
Who the study is looking for
- Patient is older than 18 years old,
- Signed participation consent,
- Non-metastatic colon cancer immediately resectable or metastatic and liver synchronous for which it was decided a combined colic and liver surgery (metastatic patient at the outset) in multidisciplinary consultation meeting.
- Performance Status (PS) 0 or 1
- affiliated to the social security or beneficiary
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Paoli-Calmettes Coordinator of this site? Confirm its status | Marseille | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.